[
  {
    "ts": "2025-11-03T08:30:00+00:00",
    "headline": "KCAS Bio Strengthens Board of Directors with Appointment of Paul Kirchgraber and Kurt Doyle",
    "summary": "OLATHE, Kan., November 03, 2025--KCAS Bio, a leading contract research organization (CRO) specializing in comprehensive bioanalytical and biomarker services, is delighted to announce the appointment of Dr. Paul Kirchgraber and Mr. Kurt Doyle to its Board of Directors. Their addition marks a significant milestone in KCAS Bio’s continued growth and strategic evolution in the global life sciences industry. KCAS Bio is headquartered in the Kansas City, Kansas metropolitan area with operating sites i",
    "url": "https://finance.yahoo.com/news/kcas-bio-strengthens-board-directors-083000439.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "9e3ce723-589b-3751-a388-a2653ccfb99b",
      "content": {
        "id": "9e3ce723-589b-3751-a388-a2653ccfb99b",
        "contentType": "STORY",
        "title": "KCAS Bio Strengthens Board of Directors with Appointment of Paul Kirchgraber and Kurt Doyle",
        "description": "",
        "summary": "OLATHE, Kan., November 03, 2025--KCAS Bio, a leading contract research organization (CRO) specializing in comprehensive bioanalytical and biomarker services, is delighted to announce the appointment of Dr. Paul Kirchgraber and Mr. Kurt Doyle to its Board of Directors. Their addition marks a significant milestone in KCAS Bio’s continued growth and strategic evolution in the global life sciences industry. KCAS Bio is headquartered in the Kansas City, Kansas metropolitan area with operating sites i",
        "pubDate": "2025-11-03T08:30:00Z",
        "displayTime": "2025-11-03T08:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/76f296dffc3757739da9419713413b91",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/P2eA8WbiOe7USP9F98EGLg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/76f296dffc3757739da9419713413b91.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Rf4mqzQLfw7BUmdrq_BUXg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/76f296dffc3757739da9419713413b91.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/kcas-bio-strengthens-board-directors-083000439.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/kcas-bio-strengthens-board-directors-083000439.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]